EUVIMEDEUVIMED entdecken
Crossref

Analysis Asks: Are GLP-1 Drugs Safe in People With Frailty?

Anna Bock

JAMA · 30.10.2026

DOI: 10.1001/jama.2026.22482 ↗

Kurz gefasst

Fachartikel in der Zeitschrift JAMA, online erschienen am 30.10.2026. Verfasst von Anna Bock. Beteiligte Einrichtung: Freelance Journalist and Physician Assistant Student, Northwestern University Feinberg School of Medicine, Chicago, Illinois.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

This Medical News article discusses an analysis of cardiovascular benefits and safety of semaglutide use in trial participants with frailty, defined by accumulated age-related health deficits.

Autor:innen und Institutionen

  • Freelance Journalist and Physician Assistant Student, Northwestern University Feinberg School of Medicine, Chicago, Illinois.

Zitieren

APA

Bock, A. (2026). Analysis Asks: Are GLP-1 Drugs Safe in People With Frailty?. JAMA. https://doi.org/10.1001/jama.2026.22482

Vancouver

Bock A. Analysis Asks: Are GLP-1 Drugs Safe in People With Frailty?. JAMA. 2026. doi:10.1001/jama.2026.22482

BibTeX
@article{Bock2026,
  author = {Bock, Anna},
  title = {Analysis Asks: Are GLP-1 Drugs Safe in People With Frailty?},
  journal = {JAMA},
  year = {2026},
  doi = {10.1001/jama.2026.22482}
}
Kostenlos starten →